Psychiatry and Neurology, Neurology · Sun City, AZ
NPI
1679692594
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
10515 W Santa Fe Dr Bldg B
Sun City, AZ, 85351
Phone (623) 832-6530
Groups this clinician bills Medicare through
Medicare paid, 2024
$174K
19,609 services
Medicare patients, 2024
332
Average age 76
Drug cost, 2024
$2.5M
3,659 prescriptions
Company payments, 2025
$2,725
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David R Shprecher was code J0585 (injection, onabotulinumtoxina, 1 unit), 10,300 times for 21 patients. In total David R Shprecher billed 19,609 services in 29 codes, and Medicare paid $174K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 10,300 | 21 | $4.75 | $49K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 414 | 222 | $11.96 | $4,953 |
| 99214 Office E&M - Established | Office | 274 | 175 | $89.64 | $25K |
| 99213 Office E&M - Established | Office | 136 | 111 | $59.21 | $8,053 |
| 99215 Office E&M - Established | Office | 111 | 90 | $130.94 | $15K |
| 64616 Musculoskeletal | Office | 38 | 16 | $134.77 | $5,121 |
| 64612 Musculoskeletal | Office | 32 | 13 | $122.22 | $3,911 |
| 99205 Office E&M - New | Office | 30 | 30 | $154.59 | $4,638 |
| 99204 Office E&M - New | Office | 27 | 27 | $116.05 | $3,133 |
| 95874 Musculoskeletal | Office | 25 | 15 | $57.25 | $1,431 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 24 | 16 | $24.11 | $579 |
| 99203 Office E&M - New | Office | 18 | 18 | $85.25 | $1,534 |
By year: 2022 $113K for 7,681 services; 2023 $105K for 7,362 services; 2024 $174K for 19,609 services.
Medicare prescription drug claims, 2024
In 2024, the drug David R Shprecher prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 486 prescriptions and refills. In total David R Shprecher wrote 3,659 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 486 | 1,332 | 167 | $22K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 228 | 554 | 70 | $17K |
| Rytary Carbidopa/Levodopa | 220 | 310 | 41 | $204K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 204 | 505 | 67 | $5,458 |
| Zonisamide Generic | 180 | 372 | 45 | $2,173 |
| Donepezil Hcl Generic | 126 | 306 | 39 | $1,331 |
| Clonazepam Generic | 119 | 174 | 30 | $923 |
| Amantadine Amantadine Hcl | 114 | 245 | 38 | $10K |
| Gabapentin Generic | 113 | 227 | 34 | $1,849 |
| Rasagiline Mesylate Generic | 91 | 233 | 28 | $20K |
| Ingrezza Valbenazine Tosylate | 84 | 88 | 14 | $732K |
| Droxidopa Generic | 81 | 95 | 11 | $167K |
| Primidone Generic | 76 | 182 | 29 | $2,624 |
| Quetiapine Fumarate Generic | 75 | 152 | 26 | $702 |
| Clozapine Generic | 66 | 66 | Under 11 | $823 |
Brand drugs: 658 claims; generic drugs: 3,001 claims; opioid claims: 63.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Shprecher $2,725 ($2,725 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $882.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $882 |
| Medtronic, Inc. MDT | 4 | $376 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $321 |
| Neurocrine BioSciences, Inc. NBIX | 4 | $318 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $200 |
| ACADIA Pharmaceuticals Inc ACAD | 3 | $194 |
| Amneal Pharmaceuticals LLC AMRX | 4 | $153 |
| UCB, Inc. UCB.BR | 2 | $137 |
| MDD US Operations, LLC | 6 | $115 |
| Merz Pharmaceuticals, LLC | 1 | $29.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.